Menu
Home
Forums
New posts
Search forums
What's new
New posts
New profile posts
Latest activity
Members
New profile posts
Search profile posts
Log in
Register
What's new
Search
Search
Everywhere
Threads
This forum
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Home
Forums
Forum Diskusi Untuk Umum
Isu Terkini Seputar Farmakologi
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Info Obat dan Regulator Obat Dunia
Prev
1
…
Go to page
Go
86
87
88
89
90
…
Go to page
Go
126
Next
First
Prev
88 of 126
Go to page
Go
Next
Last
Filters
Show only:
Loading…
F
2022 Financial Transparency and Efficiency of the Prescription Drug User Fee Act, Biosimilar User Fee Act, and Generic Drug User Fee Amendments - 06/0
FDA
May 12, 2022
Replies
0
Views
233
May 12, 2022
FDA
F
F
Generic Drugs Forum 2021: Lifecycle of a Generic Drug - 04/28/2021
FDA
May 12, 2022
Replies
0
Views
263
May 12, 2022
FDA
F
F
From Our Perspective: FDA’s Role in Helping a Critical Medical Isotope Meet Sufficient Supply in the US for First Time
FDA
May 12, 2022
Replies
0
Views
429
May 12, 2022
FDA
F
F
The Collection | From Our Perspective
FDA
May 12, 2022
Replies
0
Views
310
May 12, 2022
FDA
F
F
FDA’s Overview of Catalyst Pharms., Inc. v. Becerra
FDA
May 12, 2022
Replies
0
Views
415
May 12, 2022
FDA
F
O
Pharmcore Inc. dba Hallandale Pharmacy - 605569 - 03/11/2020
Office of Pharmaceutical Quality Operations
May 10, 2022
Replies
0
Views
267
May 10, 2022
Office of Pharmaceutical Quality Operations
O
F
Pharmcore Inc. dba Hallandale Pharmacy - 605569 - 05/03/2022
FDA
May 10, 2022
Replies
0
Views
341
May 10, 2022
FDA
F
F
Benefit-Risk Considerations for Product Quality Assessments
FDA
May 10, 2022
Replies
0
Views
256
May 10, 2022
FDA
F
F
FDA & American College of Rheumatology (ACR) Virtual Summit - 05/17/2022
FDA
May 10, 2022
Replies
0
Views
274
May 10, 2022
FDA
F
F
Rare Diseases Team
FDA
May 10, 2022
Replies
0
Views
367
May 10, 2022
FDA
F
E
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 2-5 May 2022, PRAC, 06/05/2022
EMA
May 9, 2022
Replies
0
Views
300
May 9, 2022
EMA
E
F
CDER Manual of Policies & Procedures | MAPP
FDA
May 9, 2022
Replies
0
Views
248
May 9, 2022
FDA
F
E
EMA business hours on Europe Day, Monday 9 May, , 05/05/2022
EMA
May 6, 2022
Replies
0
Views
260
May 6, 2022
EMA
E
F
Rationale for FDA's Position on Cefadroxil
FDA
May 6, 2022
Replies
0
Views
276
May 6, 2022
FDA
F
F
Notice of Updates
FDA
May 6, 2022
Replies
0
Views
318
May 6, 2022
FDA
F
F
Compounding Quality Center of Excellence
FDA
May 6, 2022
Replies
0
Views
250
May 6, 2022
FDA
F
F
FDA grants regular approval to fam-trastuzumab deruxtecan-nxki for breast cancer
FDA
May 6, 2022
Replies
0
Views
240
May 6, 2022
FDA
F
F
FDA Updates and Press Announcements on Nitrosamine in Varenicline (Chantix)
FDA
May 6, 2022
Replies
0
Views
240
May 6, 2022
FDA
F
F
Identification of Medicinal Products (IDMP)
FDA
May 6, 2022
Replies
0
Views
262
May 6, 2022
FDA
F
F
Clinical Pharmacology Considerations for Human Radiolabeled Mass Balance Studies
FDA
May 6, 2022
Replies
0
Views
221
May 6, 2022
FDA
F
Prev
1
…
Go to page
Go
86
87
88
89
90
…
Go to page
Go
126
Next
First
Prev
88 of 126
Go to page
Go
Next
Last
You must log in or register to post here.
Home
Forums
Forum Diskusi Untuk Umum
Isu Terkini Seputar Farmakologi
Top